Geographic Atrophy
📧 Sign up to get email alerts when something new happens for Geographic Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort
Completed study examining the relationship between function and structure in an ARCHER II–like population using data from a natural history …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 2]
A Phase 2 study is evaluating different doses of BI 1584862 for geographic atrophy, a form of age-related macular degeneration; the trial is…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 1, Phase 2]
An update on the ABBV-6628 intravitreal study in adults with geographic atrophy due to age-related macular degeneration, focusing on adverse…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration [Phase 1, Phase 2]
An early-stage clinical trial is evaluating autologous induced pluripotent stem cell-derived retinal pigment epithelium transplantation for …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy [Phase 2]
Phase 2 clinical trial update on dimethyl fumarate to slow geographic atrophy in age-related macular degeneration; the study is currently re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 2]
Phase 2 trial update of BI 771716 for geographic atrophy, a form of age-related macular degeneration, currently active_not_recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating intravitreal BS01 for geographic atrophy secondary to dry age-related macu…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration [Phase 1]
Phase 1 study to evaluate the safety and tolerability of ASP7317 in senior adults with geographic atrophy secondary to dry age-related macul…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy [Phase 3]
Belite Bio reports a Phase 3 randomized, placebo-controlled trial to evaluate the safety and efficacy of Tinlarebant in geographic atrophy, …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Wide Field OCTA in Ocular Diseases
Clinical trial update on a wide-field optical coherence tomography angiography (OCTA) study across several ocular diseases, sponsored by IRC…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy [Phase 1, Phase 2]
A clinical trial update indicates Kamuvudine-8 is being evaluated for Geographic Atrophy in Phase 1/2 and the study is currently active but …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: SGLT2 Inhibitors in Geographic Atrophy [Phase 2]
A Phase 2 clinical trial is evaluating SGLT2 inhibitors for geographic atrophy, an advanced form of age-related macular degeneration, and is…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe [Phase 3]
A Phase 3 trial evaluating pegcetacoplan (Syfovre) in a prefilled syringe for geographic atrophy secondary to age-related macular degenerati…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy [Phase 1, Phase 2]
Ocugen is conducting a Phase 1/2 trial to assess the safety and efficacy of OCU410 for geographic atrophy. The study status is active but no…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD [Phase 2]
A Phase 2 study evaluating ONL1204 for geographic atrophy associated with age-related macular degeneration is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) [Phase 2]
This document provides a Phase 2 multiple-dose trial update for AVD-104 in geographic atrophy secondary to age-related macular degeneration,…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA) [Phase 3]
A Phase 3 trial evaluating intravitreal vonaprument for geographic atrophy is currently active but not recruiting.
-
EMA withdrawal · 2025-10-30EMA Refused: Syfovre — Apellis Europe B.V.
The EMA refused to grant marketing authorization for Syfovre (pegcetacoplan) for geographic atrophy associated with age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD [Phase 3]
An extension study evaluating the long-term safety and efficacy of pegcetacoplan (APL-2) in geographic atrophy due to age-related macular de…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Phase 2/3 Study of ALK-001 in Geographic Atrophy [Phase 2, Phase 3]
A Phase 2/3 study of ALK-001 in Geographic Atrophy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]
Update on the VOY-101 trial for advanced non-neovascular age-related macular degeneration (geographic atrophy), a Phase 1/Phase 2 study that…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 2]
A Phase 2 study of Danicopan for geographic atrophy due to age-related macular degeneration was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD [Phase 1, Phase 2]
The FOCUS study (GT005) in dry age-related macular degeneration was terminated in Phase 1/2, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration [NA]
A completed clinical trial evaluated retinal fundus flavoprotein fluorescence in age-related macular degeneration, including geographic atro…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study of NGM621 in Participants With Geographic Atrophy [Phase 2]
Phase 2 study of NGM621 for geographic atrophy has completed with results posted on 2025-07-01.